Mentor Capital Adds Three Cannabis Investments in Two Months

G Farma, Solis Tek, and GB Sciences Increase Mentor’s Marijuana Holdings

CALIFORNIA: Mentor Capital announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. In addition to receiving consulting fees, repayment, interest, and lease payments, Mentor has captured a $1 option for a 3.75% equity Read the full article…

Study Confirms Safety Of Cannabis Drug CBD

An early American study has assessed the safety of a drug made from a compound derived from cannabis.

NEW YORK:  Using a drug based on a chemical found in the cannabis plant to treat epilepsy has been controversial to say the least. An early study from the US may lend more weight to its scientific standing, however. The study suggests that the drug is safe, well-tolerated and effective. An early American study has Read the full article…

3 Marijuana Stocks That Could Go Up in Smoke

The potential to use marijuana as a treatment for various diseases doesn't guarantee marijuana stocks will keep going higher.

DISTRICT OF COLUMBIA:  The potential to use marijuana as a treatment for various diseases has captured the attention of doctors, patients, and investors, but that doesn’t guarantee marijuana stocks will keep going higher. In fact, there are plenty of reasons why marijuana stocks could stumble. Read on to learn why our Motley Fool experts think Read the full article…

Are There Any Marijuana Stocks To Buy In 2015?

NORML Top 10 Events of 2016

DISTRICT OF COLUMBIA:  Perhaps nothing caught the eyes of speculative investors more than marijuana stocks in 2014, but just because marijuana stocks put up significant returns last year doesn’t mean that they can do it again in 2015. We asked our Motley Fool contributors to share their thoughts on whether there are any marijuana stocks Read the full article…

Making Money From Marijuana

GW Pharmaceuticals is a speculative drug company that has a history of volatile trading. However, Cramer wouldn't be surprised if the more than 10 percent jump in the stock on Wednesday is just the start of this stock being... high.

NEW YORK: Making money from marijuana in the past used to require navigating the red tape of the law.  Jim Cramer has had his eye on one stock that is giving him quite a buzz. GW Pharmaceuticals is a speculative drug company that has a history of volatile trading. However, Cramer wouldn’t be surprised if the more Read the full article…

How Cannabis-Based Drugmaker GW Finally Cracked America

GW was granted permission to supply its experimental epilepsy drug Epidiolex, never before tested on humans, to a handful of specialist paediatricians in the US to use on their patients.

GREAT BRITAIN:  When a pair of British doctors set out to make medicines from the cannabis plant 16 years ago, they knew it would take some time to crack the world’s biggest pharmaceuticals market. But Geoffrey Guy and Britain Whittle could hardly have predicted that when their company, GW Pharmaceuticals, finally did break into the Read the full article…

Georgia Governor Pushes Trials Of Marijuana Derivative

Workers at the marijuana testing lab are failing about 18 percent of the samples because of microbes such as bacteria and fungi.

GEORGIA:  Georgia’s governor is pushing clinical trials for a marijuana-derived drug that proponents say could help treat severe seizure disorders among children, an unlikely election-year move for a Republican in a conservative part of the country that is just beginning to warm up to medical marijuana in narrow circumstances. Since 1996, 23 states around the Read the full article…

GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress

Cannabis-based medicines progress.

NORTH CAROLINA:  Yesterday, Salisbury, UK-based GW Pharmaceuticals plc announced the closing of its public offering of 1.7 million American Depositary Shares on the NASDAQ Global Market. When taken together with the full exercise of options for another 255,000 ADSs by the underwriters at $86.83/ADS, the offering totaled $169.8 million. Although some of the ADRs were sold by Read the full article…

NY State To Hold Clinical Trials For Marijuana

An agreement was signed Sunday between Gov. Andrew Cuomo’s administration and GW Pharmaceuticals. The state Health Department and the company will develop the framework for a clinical trial for a marijuana-based drug for people under the age of 18.

NEW YORK: New York State is partnering with a British company to hold clinical trials for marijuana-based medication for children who have seizures that are resistant to their medicine. An agreement was signed Sunday between Gov. Andrew Cuomo’s administration and GW Pharmaceuticals. The state Health Department and the company will develop the framework for a Read the full article…

Mormon Mom Wants Medical Marijuana for Her Sick Son

Jennifer May and her son Stockton when he was a small child.

UTAH:  Jennifer May has tried 25 treatments in 10 years, a mix of prescribed diets and drugs, to quiet the lightning in her son’s brain. Only two eased Stockton May’s seizures. But their toxic side effects ravaged his bones and immune system, and the relief was temporary.